Bipolar Disorder (2018) |
1.19 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NEK4 |
Bipolar Disorder or Schizophrenia |
1.52 |
16 |
10 |
22.2 |
-0.45 |
4.7e-02 |
C2orf69 CGREF1 CNNM2 CYP2D7P1 DDHD2 FES FURIN GALNT4 HDDC3 MARK2 MPP6 NDUFA2 NEK4 NSUN6 TMEM180 ZMYM4 |
Depressed Affect (Nagel 2018) |
1.25 |
6 |
5 |
11.1 |
-0.03 |
9.6e-01 |
ACP2 ARL17B ARNTL NSF NUP160 RERE |
Depression (Nagel 2018) |
1.20 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
NDUFA2 PCCB RERE |
Intelligence (Savage-Jansen 2018) |
1.16 |
19 |
11 |
24.4 |
-0.14 |
5.6e-01 |
AC008865.1 ARL17A ATXN1L C17orf68 C2orf69 DCAF16 EDEM3 FBXO41 FBXW4 KANSL1 MYBPC3 NDUFA2 NEK4 NSF NSFP1 PREX1 SLC5A11 TRIOBP UBA7 |
Neuroticism (Nagel 2018) |
1.47 |
15 |
10 |
22.2 |
-0.19 |
4.8e-01 |
ACP2 ADM ARL17A ARL17B ARNTL CNNM2 KANSL1 MMAB NSF NSFP1 NUP160 PCCB PPP6C RERE RNF130 |
Schizophrenia (2018) |
1.61 |
12 |
5 |
11.1 |
-0.37 |
1.5e-01 |
C2orf69 CNNM2 CYP2D7P1 FES FURIN HDDC3 MARK2 NDUFA2 PCCB PCNX RERE ZMYM4 |
Worry (Nagel 2018) |
1.53 |
14 |
7 |
15.6 |
-0.21 |
4.3e-01 |
ARL17A ARL17B CADM2 CNNM2 GOLGA1 MMAB NEK4 NSF NUP160 PCCB PEPD PPP6C RP11-78O7.2 SMG6 |
Alzheimer’s Disease (including proxy) |
1.07 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ACE PRKD3 |
Crohns Disease (2017) |
1.31 |
9 |
7 |
15.6 |
0.36 |
3.4e-01 |
AC008865.1 ADO C11orf30 RASIP1 RP11-373D23.3 SLC20A2 SLC2A4RG SMAD3 UBA7 |
Irritable Bowel Disease (IBD) |
1.38 |
15 |
7 |
15.6 |
0.42 |
1.1e-01 |
AC008865.1 ADCY3 C11orf30 GABPB2 HHEX LSP1 NADK RGS19 RP11-373D23.3 SLC20A2 SLC2A4RG SMAD3 TMBIM1 TNNI2 UBA7 |
Ulcerative Colitis (UC) |
1.33 |
5 |
2 |
4.4 |
0.87 |
2.2e-03 |
LSP1 OPRL1 RGS19 TNNI2 UBA7 |
Major Depression (MDD) |
1.30 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Reaction Time |
1.56 |
10 |
8 |
17.8 |
-0.13 |
7.1e-01 |
ARL17A BRAP C2orf69 KANSL1 NAA25 NSF NSFP1 OLA1 PHF21A SH2B3 |
Verbal and Numeric Reasoning (VNR) |
1.21 |
10 |
4 |
8.9 |
-0.49 |
1.5e-01 |
ATXN1L C17orf68 C2orf69 DCAF16 FBXO41 MYBPC3 NEK4 PREX1 SLC5A11 UBA7 |
Breast Cancer |
2.27 |
20 |
9 |
20.0 |
0.13 |
5.1e-01 |
ADCY3 ADCY9 CPEB4 CSK CTC-228N24.3 FES FIBP FURIN HDDC3 LDB1 MMACHC NSF SGSM3 SLC4A7 SNX32 TCF7L2 TNNT3 TOM1L2 TOX3 ZCCHC10 |
Ovarian Cancer |
1.23 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARL17B HOXB4 RP11-6N17.6 |
Prostate Cancer |
1.34 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
C11orf30 SKAP2 |
Age at First Birth |
1.14 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
UBA7 |
Bipolar Disorder (2011) |
1.55 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
NEK4 |
Body Mass Index (BMI) (2010) |
1.43 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MYBPC3 TRIM73 |
Coronary Artery Disease (CAD) |
1.98 |
5 |
1 |
2.2 |
0.39 |
5.2e-01 |
CNNM2 MRAS PPAP2B RP1-257A7.5 TCF21 |
Crohns Disease (2012) |
1.24 |
5 |
4 |
8.9 |
-0.17 |
7.8e-01 |
AC008865.1 RASIP1 SLC2A4RG SMAD3 UBA7 |
Fasting Glucose |
1.34 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ACP2 CGREF1 |
HbA1C |
1.01 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADAM1A |
HDL Cholesterol |
1.37 |
10 |
3 |
6.7 |
-0.62 |
4.3e-02 |
ACP2 ADRB1 GRB14 MYBPC3 MYO5B PIGV RAC1 RP11-244F12.3 SIPA1 SNX32 |
LDL Cholesterol |
1.33 |
6 |
2 |
4.4 |
-0.22 |
6.7e-01 |
BRAP MKRN2 RASIP1 SCRN2 SH2B3 SMARCA4 |
Lupus |
1.20 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARID5B PLEKHJ1 TCP11 |
Neuroticism (2016) |
1.22 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADM NUP160 |
Primary Biliary Cirrhosis |
1.17 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
SH2B3 TRIM59 |
Rheumatoid Arthritis |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARID5B SH2B3 |
Schizophrenia (2014) |
1.58 |
14 |
7 |
15.6 |
-0.34 |
1.7e-01 |
C2orf69 CERS5 CGREF1 CNNM2 CYP2D7P1 FES FURIN HDDC3 MARK2 NEK4 PCCB PCNX RERE TOM1L2 |
Triglycerides |
1.27 |
7 |
5 |
11.1 |
0.95 |
1.3e-03 |
CGREF1 GRB14 IFT172 RGS12 RP11-373D23.3 SIDT2 ZNF557 |
Type 2 Diabetes (T2D) (2012) |
1.49 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
HHEX LRIG1 TCF7L2 |
Ulcerative Colitis |
1.26 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
LSP1 TMBIM1 TNNI2 |
Blood Eosinophil Count |
1.67 |
70 |
53 |
117.8 |
0.43 |
1.3e-04 |
AC006547.13 AC006547.14 AC010883.5 AC074212.6 ACADVL ACAP1 ADAM1A ADRB2 ARL17B ARVCF BRAP C11orf30 CDK6 CERS5 CLIC4 CPEB4 CTC-228N24.3 DCUN1D3 EFCAB13 ELP5 FIBP FLJ33630 FOXJ3 FUT11 GABPB2 GALNT4 GLTP HHEX HTR4 KAT5 LIMA1 MED19 NAA25 NAT15 NEK4 NFKBIA NNT NSF OIP5-AS1 PDXK PHACTR4 PIGV PLCD3 POC1B PSMB7 RERE RP11-156P1.3 RP11-981P6.1 RP5-1029K10.2 RTF1 SFXN2 SH2B3 SIPA1 SMAD3 SNF8 SNX32 SPRY4 TCP11 TEAD3 THAP9-AS1 TMEM116 TOM1L2 TP53INP1 TRAFD1 TRIM47 TRIM8 TRPV4 UBA7 UBE2Z ZNF831 |
Blood Platelet Count |
1.91 |
129 |
98 |
217.8 |
0.09 |
2.9e-01 |
AC006547.13 AC006547.14 AC010883.5 AC015936.3 AC074212.6 ADAM11 ADAM1A ADAMTS13 ADO ANKS3 ARID5B ARL17A ARVCF ATF1 ATXN1L C10orf107 C4orf3 C8orf58 CARF CDK6 CERS5 CGREF1 CHD6 CLIC4 CRK CSK CTSZ DCAF16 DCUN1D3 DIP2B DKFZp686O24166 DNAJC18 DYDC2 EDEM3 ERAP1 FER FIBP GOSR2 GPAM GPR137 GTF2B HDAC7 HDDC3 HELLS HM13 IFT172 IPO11 IRAK1BP1 ITGA9 JPH2 KAT5 LDB1 LFNG LIMA1 LIME1 LRRC55 MAP6D1 MED28 MEGF9 MMACHC MPP6 MRPL24 MTHFR MYBPC3 NAA25 NEK4 NELFCD NMT1 NSFP1 NUDT16L1 OBFC1 OCIAD1 PAFAH1B1 PCCB PEX1 PHOSPHO2 PIGV PNMA1 POC1B PPAP2B PSMB7 PSMD5-AS1 RASIP1 RGS12 RHOBTB1 RHOC RNPS1 RP11-244F12.3 RP11-373D23.3 RP11-6N17.6 RP11-78O7.2 RP11-981P6.1 RP13-514E23.2 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 RPS6KL1 SAV1 SENP1 SEPT12 SGCD SH2B3 SIDT2 SIPA1 SIRT1 SLC25A37 SLC2A4RG SLC4A7 SMG6 SNF8 SNX16 SNX32 TEAD3 TH1L TMBIM1 TMEM116 TMEM170A TRABD TRAF3IP3 TRIM8 TRPV4 TUBB1 UBE2Z UBN1 WDR66 WNT2B YES1 ZNF318 ZNF500 |
Blood Red Count |
1.32 |
89 |
69 |
153.3 |
0.17 |
9.1e-02 |
AC010883.5 ACTRT3 ADAM1A ADM ARL17B ARNTL BRAP C17orf69 C1orf84 C2orf69 CBWD1 CCDC158 CLCN6 CLIC4 CNNM2 CPEB4 CRK CSK CTSZ CYB5D1 EIF2AK4 ELP4 EXD1 GCHFR GOSR2 GRB14 GTF2B HELLS HHEX HM13 HOXB4 HOXB9 IFT172 INO80 ITSN1 LRRC46 MAPKAP1 MAPKBP1 MC1R MKRN2 MMACHC MTHFR MYBPC3 MYLPF NAA16 NAA25 NEK4 NELFCD NME6 NOV NPPA NSF NUP160 OBFC1 PAWR PBX3 PDXK PEX1 PHF21A PLCD3 PLEKHH2 POLI RP11-156P1.3 RP11-332H18.4 RP11-6N17.6 RPS6KB1 RTF1 SCRN2 SENP1 SH2B3 SLC20A2 SLC2A4RG SLC9A3R2 SMOC1 ST5 TH1L TMEM116 TMEM87B TP53INP1 TRAFD1 TRIM8 TRIOBP TUBB1 UBA7 UBE2E3 ULK4 WDR66 ZNF100 ZNF443 |
Blood White Count |
1.65 |
75 |
55 |
122.2 |
0.48 |
1.5e-06 |
AC006547.13 AC006547.14 AC010883.5 ACP2 ADAM1A ADRB2 APOLD1 ARHGAP42 ARVCF ATF1 BHLHE41 BRAP C10orf118 C1orf84 C4orf3 CCT6A CDK6 CERS5 CGREF1 CRK CSNK1G3 CTC-228N24.3 CYB5D1 DCAF16 DENND3 DMXL1 FBXO38 FER FES FLJ33630 FURIN GLYR1 HELLS HOXC8 HTR4 IFT172 LA16c-358B7.3 LIMA1 MC1R MYBPC3 NAA16 NAA25 NFKBIA NNT NUDT16L1 NUP160 PAWR PLA2G4B PLCB1 POLI PSMB7 RERE RP11-373D23.3 RP11-6N17.6 RP11-78O7.2 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 RTF1 S1PR2 SGCD SGOL1 SH2B3 SIRT1 SLC5A11 SLC9A3R2 THAP9-AS1 TMEM116 TMEM87B TOM1L2 TRAF3IP3 TRAFD1 TRPM7 UBA7 UBE2E3 |
Heel T-Score |
1.62 |
88 |
64 |
142.2 |
0.17 |
8.7e-02 |
AC015936.3 ACP2 ADCY9 ARHGAP42 ARID5B ARL14EP ARL17A ARL17B BHLHE41 BICC1 C17orf69 CARF CBWD1 CDK6 CES2 CHD6 CNNM2 CPEB2 CPEB4 CSNK1G3 CYB5D1 CYBRD1 DCAF16 DDX5 DNAJC18 DYDC2 ELP5 ERAP1 FHL3 FLJ33630 GLS GTF2B HM13 IBA57 KANSL1 KAT5 KIF18B LDB1 LFNG LOC441601 LRIG2 LRRC55 NELFCD NMT1 NOV NSF NSFP1 NUP160 PEX1 PHF21A PLEKHM2 PLN PRSS3 PSMB7 RERE RP11-166B2.1 RP11-981P6.1 RP13-514E23.2 RP4-635E18.7 RPS2 RPS6KL1 SEC31B SENP2 SGIP1 SIPA1 SLC5A11 SLC9A3R2 SMG6 SNX32 SOX6 ST5 STYX TCF7L1 TCP11 THAP3 TMBIM1 TMEM87B TRABD TRIOBP UBA7 UBE2E3 UGGT1 VGLL4 WNT2B ZCCHC10 ZNF318 ZNF827 ZNRF3 |
BMI |
1.48 |
63 |
43 |
95.6 |
-0.20 |
8.7e-02 |
AC006547.14 AC091133.1 ACP2 ADCY3 ADCY9 AP001816.1 ARL14EP ARNTL ARVCF C2orf69 C4orf22 C6orf142 CARF CNNM2 CPEB4 DHX36 DNAJC3-AS1 ERAP1 FAM108C1 FIBP GALNT4 GFPT1 GRB14 HTR4 KDM2B LRIG1 MYBPC3 NADK NEK4 NUP160 OLA1 PEPD PLEKHM2 POC1B PPAP2B RGS19 ROGDI RP11-179B2.2 RP11-981P6.1 RP13-870H17.3 RSRC2 SENP2 SFXN2 SFXN3 SGSM3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SNF8 SNX11 SNX32 ST5 TCF7L2 TEAD3 THAP3 TRIM47 TRIM73 TRIM8 UBA7 UBE2Z UBN1 |
Height |
1.77 |
185 |
156 |
346.7 |
-0.34 |
4.2e-07 |
AC010883.5 AC074212.6 AC091133.1 ACAP1 ACE ACP2 ADAM11 ADCY3 ADCY9 ADM ADO ADRB1 ANKS3 ARC ARHGAP42 ARID5B ARL14EP ARL17A ARL17B ATF1 ATXN1L AZI1 C11orf30 C17orf104 C17orf68 C1orf84 CCNT2 CCT6A CDK6 CENPW CERS5 CGREF1 CLIC4 COPB1 CRK CRLF3 CSNK1G3 CTD-2203K17.1 CYBRD1 CYTH1 DCAF16 DDX5 DHX36 DKFZp686O24166 DNAJC18 DPCD EDEM3 EFCAB13 EXD1 FBXW4 FER FES FGGY FHL3 FLJ33630 FURIN GAB1 GAPVD1 GCHFR GFER GFPT1 GLYR1 GOLGA1 GOPC GOSR2 GTF2B HADH HM13 INO80 ITSN1 KANK2 KANSL1 KCNG3 KIAA0753 KIF5B LIMA1 LRIG2 LSM11 LSP1 MAP6D1 MAPKAP1 MEA1 MED19 MED28 MMACHC MPP6 MRPL24 MXD4 MYBPC3 MYLPF NEK4 NFKBIA NMT1 NOC3L NOV NPR3 NSF NSFP1 NUDT16L1 NUP160 OAF OCIAD1 OIP5-AS1 PBX3 PCCB PEX1 PHF21A PIGV PLCD3 POLL POLN PPP2R2D PPP3R1 PPP6C PREX1 PSMD5-AS1 PTPN12 PUSL1 RABGAP1 RABL2A RASIP1 RERE RGS12 RHOC ROGDI RP11-1055B8.4 RP11-166B2.1 RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP11-379F4.7 RP13-514E23.2 RP4-605O3.4 RP4-635E18.7 RP5-1029K10.2 RPL39P5 RPS6KL1 RSRC2 RTF1 RYK S1PR2 SAV1 SCRN2 SEC23IP SENP2 SENP3 SEPT12 SFXN2 SH2B3 SIPA1 SLC25A37 SLC4A7 SLC5A11 SLC9A3R2 SLFNL1 SMARCA4 SMG6 SMOC1 SNF8 SNX11 SNX32 SRD5A3 SRPK1 TCP11 TEX2 TMBIM1 TMEM170A TMEM180 TRIM73 TRIOBP TRPM7 UBE2Z UBN1 UBXN2A UGGT1 UPF3A UQCC1 WNT2B ZFP1 ZNF318 ZNF500 ZNF557 ZNF585B ZNF827 ZNF831 |
Waist Hip Ratio (WHR) |
1.83 |
52 |
41 |
91.1 |
0.55 |
3.5e-06 |
ADAM1A ADCY3 ADM BHLHE41 C22orf31 CASC7 CFHR4 CPEB4 CTC-228N24.3 CTD-3032J10.3 DKFZp686O24166 DMXL1 FLJ33630 GABPB2 GAPVD1 GPAM GPR137 GRB14 HOXC8 ITGA9 KAT5 MAPKBP1 MEA1 MKRN2 MRAS MRVI1 NEK4 OPRL1 PCCB PCNX PDCL2 PEPD PLA2G4B PPP6C PTPN12 RASIP1 RGS19 RP11-156P1.3 RP11-332H18.4 RSRC2 SIPA1 SNX32 SRD5A3 SWAP70 TCF7L2 TMBIM1 TOM1L2 UQCC1 ZCCHC10 ZMYM4 ZNF318 ZNRF3 |
Smoking Status |
1.49 |
14 |
8 |
17.8 |
-0.38 |
1.1e-01 |
ADAM1A ARL17B C17orf75 CADM2 GAPVD1 GOLGA1 MAPKAP1 PBX3 PDXDC2P PPP6C RERE SLC5A11 SMG6 UBE2E3 |
Allergy or Eczema |
1.55 |
23 |
14 |
31.1 |
0.28 |
1.9e-01 |
ADAM1A C11orf1 C11orf30 CFHR4 EXD1 GCHFR INO80 KDM2B LIME1 OIP5-AS1 PLEKHM2 POLI PSMB7 RERE RP11-373D23.3 RP5-1029K10.2 RTF1 SLC15A2 SLC2A4RG SMAD3 TMBIM1 TMEM170A ZMYM4 |
Cardiovascular Disease |
6.12 |
189 |
121 |
268.9 |
0.97 |
2.1e-147 |
AC006111.1 AC006547.13 AC006547.14 AC010883.5 AC091133.1 ACADVL ACE ACP2 ACTRT3 ADAM1A ADO ADRB1 ADRB2 AGT AGTRAP ARHGAP42 ARL14EP ARL17A ARNTL ARVCF ATP2B1 BRAP C10orf118 C11orf1 C22orf31 C4orf22 CACNB2 CDK6 CENPW CEP68 CERS5 CGREF1 CLCN6 CLIC4 CNNM2 CPEB4 CRK CRLF3 CSK CTC-228N24.3 CTD-3032J10.3 CTSZ CYB5D1 CYTH1 DCAF16 DKFZp686O24166 DMXL1 EFCAB13 ENPEP ERAP1 EXD1 FAM108C1 FBXO41 FCN3 FES FGF5 FMNL3 FURIN FUT11 GAB1 GCHFR GLTP GLYR1 GOPC GOSR2 GTF2B GUCY1A3 HELLS HIBADH HOXA10 HOXB9 HOXC8 HRCT1 HTR4 HTRA1 IFT172 INO80 IPO11 IRAK1BP1 ITGB3 ITGB5 KANK2 KDM2B LA16c-358B7.3 LFNG LIMA1 LOC441601 LSP1 MAPKAP1 MCF2L-AS1 MED21 MRAS MRPL35 MTHFR NAA25 NAT15 NEDD4L NELFCD NFKBIA NME6 NMT1 NOC3L NPPA NSF NSFP1 NSUN6 NUP160 OIP5-AS1 OLA1 OPRL1 PCCB PCNX PDXK PIGV PLA2G4B PLCB1 PLEKHM2 POC1B PPP3R1 PRDM8 RASIP1 RGS12 RGS19 RHOC RP11-1055B8.4 RP11-332H18.4 RP11-373D23.3 RP11-379F4.7 RP11-513M16.7 RP11-588K22.2 RP11-819C21.1 RP11-981P6.1 RP13-514E23.2 RP4-605O3.4 RP4-635E18.7 RP5-1029K10.2 RTF1 RYK SENP1 SENP3 SEPT12 SFXN2 SGIP1 SH2B3 SIDT2 SIPA1 SLC12A2 SLC2A4RG SLC4A7 SMARCA4 SNF8 SNX16 SNX32 SOX6 SPEN SPRY4 SRD5A3 SWAP70 TCF21 TEX2 TH1L THAP3 TMBIM1 TMEM116 TMEM170A TMEM26 TMEM87B TNNI2 TNNT3 TP53INP1 TRAFD1 TRIM47 TRIM59 TUBB1 UBE2E3 UBE2Z UPF3A VGLL4 WIPF1 WNT2B YES1 ZBTB46 ZCCHC10 ZNF100 ZNF318 ZNF443 ZNF557 ZNF831 ZNRF3 |
Hypothyroidism (self reported) |
1.51 |
15 |
7 |
15.6 |
0.39 |
1.5e-01 |
ADAM1A ANKRD65 ARID5B BRAP FHL3 NAA25 PSMB7 PSMD5-AS1 PUSL1 RASIP1 RERE RP11-6N17.6 SH2B3 SLC25A37 UBE2E3 |
Respiratory disease |
1.43 |
10 |
7 |
15.6 |
0.52 |
1.0e-01 |
AC074212.6 DDX5 HHEX OIP5-AS1 RERE RP5-1029K10.2 RTF1 SLC2A4RG SMAD3 TCP11 |
Type 2 Diabetes (T2D) (2018) |
1.73 |
9 |
5 |
11.1 |
0.72 |
2.0e-02 |
DKFZp686O24166 GRB14 HHEX MAPKBP1 PLA2G4B SNX32 TCF7L2 UBA7 ZBTB46 |
Lung FEV1/FVC ratio |
1.68 |
52 |
33 |
73.3 |
-0.24 |
7.8e-02 |
AC074212.6 ADCY3 ADM ADO AFAP1 ARHGAP42 ATP2B1 ATP8B3 C22orf31 CACNB2 CARF CASC7 CPEB4 CTC-228N24.3 CYB5D1 CYP46A1 DDX5 DHX36 DYDC2 FBXO38 FLJ33630 FTOP1 GFPT1 GOPC HAAO HELLS HOXC8 HOXD-AS1 HTR4 KCNG3 MAPKBP1 MMACHC MRVI1 NFKBIA NOV PLA2G4B PNMA1 RASIP1 RERE RP11-244F12.3 RP5-1029K10.2 S1PR2 SLC24A3 SMAD3 SNX11 TCP11 THAP3 TMEM170A TRIOBP ULK4 VGLL4 ZCCHC10 |
Lung FVC |
1.43 |
55 |
32 |
71.1 |
-0.18 |
1.5e-01 |
ABLIM3 ACADVL ADAM11 ARID5B ARL17A ARL17B C17orf69 C8orf58 CFHR4 COMMD7 CRK CTC-228N24.3 DCAF16 DDHD2 EXD1 FLJ33630 FMNL3 GABPB2 GCHFR GFPT1 HM13 HOXA10 HOXC8 HTR4 INO80 KANSL1 NAT15 NDUFA2 NOV NSF NSFP1 OPRL1 PDXDC2P RGS19 RP11-1055B8.4 RP11-156P1.3 RP11-332H18.4 RP11-379F4.7 RP11-6N17.6 RTF1 SIDT2 SLC12A2 SLC2A4RG SNX31 SOX6 TCF21 TCP11 TRIOBP UBA7 UBXN2A UQCC1 WNT2B ZBTB46 ZCCHC10 ZNF500 |
Neuroticism |
1.52 |
21 |
11 |
24.4 |
-0.31 |
1.4e-01 |
ADM ARL17A ARL17B ARNTL CADM2 CNNM2 ELP4 FES FIGN FURIN GOLGA1 KANSL1 MMAB NSF NSFP1 NUP160 PCCB PPP6C RERE RNF130 RPS6KL1 |
Chronotype (morning person) |
1.09 |
8 |
2 |
4.4 |
0.38 |
3.6e-01 |
ACP2 BRAP C10orf26 HOXB3 MARCH10 NAA25 PSMB7 TMEM116 |
Hair Pigment |
1.89 |
46 |
32 |
71.1 |
0.06 |
6.1e-01 |
AC006547.14 ACP2 ADM ANKRD65 ARL17A ARVCF ATP2B1 BHLHE41 BRAP C22orf31 C4orf22 CBWD1 CGREF1 COMMD7 FES FGF5 GALNT4 GOSR2 HM13 IFT172 KAT5 LRRC46 MC1R NDUFS4 OPRL1 PCNX PIGV POC1B RGS19 RP11-156P1.3 RP11-373D23.3 RP11-6N17.6 RP11-981P6.1 RP5-1087E8.3 SCRN2 SH2B3 SIDT2 SIPA1 SNX11 SNX32 SOX6 TOX3 UQCC1 WDPCP ZNF831 ZNRF3 |
Tanning |
1.17 |
11 |
8 |
17.8 |
-0.26 |
4.5e-01 |
ADCY3 ADO CADM2 COMMD7 GABPB2 MC1R MYBPC3 RP5-1087E8.3 SH2B3 SNX11 UQCC1 |
Hand grip strength (left) |
1.56 |
27 |
6 |
13.3 |
-0.04 |
8.4e-01 |
ADAM11 ADCY3 ARL17B C17orf104 DCAF16 FBXW4 FER GFER GOLGA1 MYBPC3 NMT1 NSF NUDT16L1 PLCD3 PPP3R1 RP11-379F4.7 RP11-6N17.6 RP1-257A7.5 SFXN2 SLC5A11 SLC9A3R2 SNX11 TCP11 TNNT3 TRIOBP UQCC1 ZNF500 |
Number of treatments/medications taken |
2.07 |
11 |
5 |
11.1 |
0.88 |
3.8e-04 |
ACE ARHGAP42 CGREF1 DCAF16 FAM108C1 FBXO41 NUDT16L1 PPP2R2D SH2B3 UBA7 ZNF831 |
Average weekly spirits intake |
1.18 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RASIP1 |
Sensitivity / hurt feelings |
1.44 |
6 |
3 |
6.7 |
-0.79 |
1.9e-02 |
AC099850.1 ARL17B FES FURIN NSF SNF8 |
Hearing difficulty/problems: Yes |
1.16 |
4 |
1 |
2.2 |
-0.58 |
4.2e-01 |
ABLIM3 FUT11 MMACHC ZNF318 |
Relative age of first facial hair |
1.23 |
11 |
6 |
13.3 |
-0.49 |
1.2e-01 |
ARL17B C17orf69 C4orf22 CCNT2 CHD6 FGF5 MC1R NSF RP11-156P1.3 RP11-179B2.2 VGLL4 |
Ever had hysterectomy (womb removed) |
1.06 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
OBFC1 |
Systolic blood pressure, automated reading |
7.74 |
236 |
140 |
311.1 |
0.99 |
1.6e-225 |
ABCA12 ABHD17C AC006111.1 AC006547.14 AC074212.6 AC099850.1 ACADVL ACP2 ACTRT3 ADCY3 ADM ADO ADRB1 ADRB2 AGT ANKRD65 ARHGAP42 ARID5B ARL14EP ARL17A ARL17B ARVCF ATP2B1 ATP8B3 AZI1 BICC1 BRAP C10orf26 C17orf69 C17orf75 C1orf84 C22orf31 C4orf22 CACNB2 CCNT2 CDK6 CEP68 CERS5 CLCN6 CNNM2 COL21A1 CPEB2 CPEB4 CRK CSK CTC-228N24.3 CYP46A1 CYTH1 DCAF16 DKFZp686O24166 DOCK6 DULLARD EDEM3 EIF2AK4 EML1 EXD1 FAM108C1 FBXO38 FBXO41 FER FES FGF5 FGGY FHL3 FIBP FIGN FMNL3 FOXJ3 FURIN FUT11 GCHFR GLTP GLYR1 GOPC GOSR2 GTF2B HDAC7 HDDC3 HELLS HOXA10 HOXB3 HOXB4 HOXB9 HOXC8 HOXD-AS1 HTR4 IGFBP3 INO80 IPO11 IRAK1BP1 ITGA9 ITGB3 ITGB5 JPH2 KANSL1 LFNG LIMA1 LIME1 LOC441601 LOC441869 LRIG2 LSP1 MAP1B MAP6D1 MAPK4 MAPKAP1 MARK2 MATN3 MCF2L-AS1 MED19 MED21 MEGF9 MMACHC MPP6 MTHFR NAA25 NADK NAT15 NEK4 NFKBIA NME6 NMT1 NOC3L NOV NPR3 NSF NSFP1 NSUN6 NUDT16L1 NUP160 OBFC1 OCIAD1 OIP5-AS1 OLA1 OLFML2A OPRL1 PAFAH1B1 PDCL2 PDXDC2P PEX1 PIGV PLA2G4B PLEKHH2 PLEKHJ1 PLEKHM2 PNPT1 POC1B PPAP2B PPP3R1 PPP6C PSMB7 PUSL1 RABL2A RBM23 RERE RGS19 RHOC RNPS1 RP11-1055B8.4 RP11-244F12.3 RP11-332H18.4 RP11-379F4.7 RP11-588K22.2 RP11-6N17.6 RP11-78O7.2 RP11-819C21.1 RP11-841O20.2 RP11-981P6.1 RP1-257A7.5 RP13-514E23.2 RP4-605O3.4 RP4-647C14.2 RP5-1029K10.2 RPS6KB1 RPS6KL1 S1PR2 SCRN2 SENP3 SERPINI1 SFXN2 SGIP1 SH2B3 SIPA1 SIRT1 SKAP2 SLC12A2 SLC16A1 SLC20A2 SLC2A4 SLC2A4RG SLC35E2 SLC4A7 SLC5A11 SLC9A3R2 SLFNL1 SMG6 SNX11 SNX24 SNX32 STYX SWAP70 TBC1D19 TCP11 TEAD3 TEX2 TMBIM1 TMEM170A TMEM87B TNNI2 TNNT3 TNS3 TOX3 TRAFD1 TRIM59 TRIM73 TRPM7 TRPV4 TSNARE1 UBA7 UBAP1 UBE2Z UBXN2A UFL1 UGT2B7 ULK4 UPF3A VGLL4 WNT2B YES1 ZBTB46 ZNF318 ZNF500 ZNF557 ZNF827 ZNF831 ZNRF3 |
Eye problems/disorders: Diabetes related eye disease |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
TCF7L2 |
Angina |
1.99 |
6 |
3 |
6.7 |
0.77 |
6.0e-03 |
FES FURIN OPRL1 RGS19 RP1-257A7.5 TCF21 |
Medication: Metformin |
1.52 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
HHEX TCF7L2 |
Diabetes (father) |
1.31 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
SNF8 TCF7L2 |
Diabetes (mother) |
1.25 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCF7L2 |
Impedance of leg (right) |
2.05 |
66 |
45 |
100.0 |
0.44 |
4.0e-05 |
AC006547.14 AC091133.1 ADCY3 ADM ARC ARVCF ATF1 C17orf69 C2orf69 C4orf3 C8orf58 CASC7 CERS5 CNNM2 CSNK1G3 CTC-228N24.3 CTD-3032J10.3 CYBRD1 DDHD2 DKFZp686O24166 ELP4 FAM108C1 FER FES FIBP FLJ33630 FURIN GABPB2 GAPVD1 GOLGA1 HAGH HELLS HOXB3 HOXC8 HOXD-AS1 IGFBP3 JPH2 LIMA1 NADK NEK4 NNT NOC3L PAFAH1B1 PASK PLA2G4B PLCD3 PPAP2B PPP6C PRRC2B RNF130 RP11-179B2.2 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 SCRN2 SENP1 SFXN2 SLC12A2 SLC35E2 SWAP70 TEAD3 TRIM73 TRIM8 UBA7 UQCC1 WNT2B |
Leg fat-free mass (left) |
1.84 |
66 |
40 |
88.9 |
-0.44 |
7.1e-05 |
AC006547.14 ADAM11 ADCY9 ARVCF C10orf118 C2orf69 CADM2 CDK6 CENPW CNNM2 CPEB4 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 FAM108C1 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 KANSL1 LRRC46 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP13-514E23.2 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SNX11 SRPK1 TCP11 TEAD3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 UPF3A UQCC1 ZNF500 |
Trunk fat percentage |
1.62 |
41 |
23 |
51.1 |
-0.10 |
5.3e-01 |
ABHD17C ADCY3 ADM ARL17A ARL17B ARNTL DHX36 EDEM3 GFPT1 GRB14 HOXA10 HOXC8 HTR4 KANSL1 KIF5B MC1R MRAS MYBPC3 NSF NSFP1 PDCL2 PEPD POC1B POLL RERE RP11-981P6.1 RSRC2 SENP3 SFXN3 SLC25A37 SLC5A11 SLC9A3R2 SNX11 SRD5A3 SRPK1 THAP3 TRIM47 TRIM73 UBA7 UPF3A WNT2B |
Hand grip strength (right) |
1.56 |
18 |
11 |
24.4 |
-0.22 |
3.3e-01 |
ADAM11 ADCY3 CYBRD1 DCAF16 GFER GOLGA1 NMT1 PLCD3 PPP3R1 RHOC RP11-379F4.7 SFXN2 SLC5A11 SLC9A3R2 SLFNL1 TNNT3 UQCC1 WNT2B |
Current tobacco smoking |
1.43 |
4 |
2 |
4.4 |
-1.00 |
3.1e-06 |
GOLGA1 MAPKAP1 PBX3 PPP6C |
Average weekly fortified wine intake |
0.99 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SLC5A11 |
Maternal smoking around birth |
1.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC5A11 |
Fed-up feelings |
1.26 |
7 |
1 |
2.2 |
-0.07 |
8.8e-01 |
ARL17B ARNTL ELP5 NUP160 RPS6KL1 SH2B3 SLC5A11 |
Relative age voice broke |
1.02 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARL17B UQCC1 |
Taking other prescription medications |
1.19 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
SH2B3 UBA7 |
Age when periods started (menarche) |
1.24 |
14 |
5 |
11.1 |
-0.60 |
1.8e-02 |
ARNTL AZI1 C1orf84 EXD1 FIBP INO80 LSP1 MEA1 NEK4 NFKBIA SNX32 ST5 TNNI2 TRIM73 |
Bilateral oophorectomy (both ovaries removed) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
OBFC1 |
Heel bone mineral density (BMD) T-score, automated (left) |
1.32 |
15 |
8 |
17.8 |
0.42 |
1.0e-01 |
CDK6 CSNK1G3 CYB5D1 FHL3 KAT5 LRRC55 PHF21A RERE RP13-514E23.2 SIPA1 UBA7 UBE2E3 WNT2B ZNF827 ZNRF3 |
High blood pressure |
6.14 |
153 |
91 |
202.2 |
0.98 |
3.2e-120 |
ABCA12 AC006111.1 AC091133.1 ACADVL ACE ACP2 ACTRT3 ADAM1A ADO ADRB1 ADRB2 AGT ANKS3 ARHGAP42 ARL17B ARNTL ATP2B1 BICC1 BRAP C10orf118 C11orf1 C22orf31 C4orf22 CACNB2 CASC7 CENPW CERS5 CLCN6 CNNM2 CSK CTD-3032J10.3 CTSZ CYB5D1 DCAF16 DKFZp686O24166 EBF2 ENPEP ERAP1 EXD1 FAM108C1 FCN3 FES FGF5 FURIN GAB1 GCHFR GLTP GLYR1 GOPC GOSR2 GTF2B HDAC7 HELLS HOXA10 HOXB9 HOXC8 HRCT1 HTR4 INO80 IPO11 IRAK1BP1 ITGB5 KDM2B LA16c-358B7.3 LFNG LIMA1 LIME1 LSP1 MAPKAP1 MARK2 MECR MED21 MRAS MTHFR NAA25 NAT15 NELFCD NME6 NMT1 NOC3L NPPA NPR3 NSUN6 NUDT16L1 NUP160 OIP5-AS1 OLA1 OPRL1 PDXK PIGV PLA2G4B PLCB1 PLEKHM2 PRDM8 PRKD3 PTPN12 RASIP1 RGS19 RHOC RP11-332H18.4 RP11-373D23.3 RP11-379F4.7 RP11-588K22.2 RP11-819C21.1 RP11-981P6.1 RP13-514E23.2 RP4-605O3.4 RP4-635E18.7 RSRC2 RTF1 RYK SENP1 SENP3 SFXN2 SGOL1 SH2B3 SIPA1 SKAP2 SLC17A6 SLC25A37 SLC2A4 SLC4A7 SLC5A11 SNF8 SNX16 SNX31 SOX6 SPEN ST5 SWAP70 TBC1D19 TH1L THAP3 TMEM116 TMEM26 TNNI2 TNNT3 TRAFD1 TRIM47 TRIM59 TUBB1 UBAP1 UBE2E3 UBE2Z UFL1 UPF3A VGLL4 WNT2B ZBTB46 ZNF318 ZNF443 ZNF831 ZNRF3 |
Hayfever, allergic rhinitis or eczema |
1.42 |
17 |
9 |
20.0 |
0.46 |
6.5e-02 |
ADAM1A C11orf1 C11orf30 C17orf69 EXD1 GCHFR INO80 MEGF9 OIP5-AS1 PSMB7 PSMD5-AS1 RERE RP11-373D23.3 RTF1 SLC15A2 SLC2A4RG SMAD3 |
Supplements: Glucosamine |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ADO |
Medication: Atenolol |
2.79 |
5 |
2 |
4.4 |
0.97 |
1.8e-05 |
ARHGAP42 CLCN6 FES FURIN SH2B3 |
Medication: Levothyroxine sodium |
1.47 |
9 |
5 |
11.1 |
0.81 |
8.4e-03 |
ADAM1A ARID5B BRAP NAA25 PUSL1 RP11-6N17.6 SH2B3 TMEM116 TRAFD1 |
Sitting height |
1.61 |
89 |
56 |
124.4 |
-0.14 |
1.7e-01 |
AC074212.6 ADAM11 ADCY3 ADM ADRB1 APOLD1 ARL14EP ARL17A ARL17B ATF1 C10orf118 CDK6 CENPW CERS5 CSNK1G3 CYBRD1 DCAF16 DNAJC18 EXD1 FAM108C1 FBXW4 FHL3 GAPVD1 GLYR1 GOPC GOSR2 GTF2B HELLS HIBADH HM13 IGFBP3 KANSL1 LDB1 LIMA1 MAPKAP1 MED28 MMACHC MRPL24 MYBPC3 NDUFA2 NFKBIA NMT1 NOV NPR3 NSF NSFP1 NUDT16L1 NUP160 OIP5-AS1 PBX3 PEX1 PLCD3 PPP3R1 PPP6C PREX1 RASIP1 RGS12 RP11-1055B8.4 RP11-179B2.2 RP11-379F4.7 RP4-605O3.4 RP5-1029K10.2 RPL39P5 RSRC2 RTF1 S1PR2 SEPT12 SLC25A37 SLC4A7 SLC9A3R2 SLFNL1 SMOC1 SNF8 SRD5A3 SRPK1 TMBIM1 TMEM180 TNNT3 TRIOBP UBE2Z UBN1 UBXN2A UPF3A UQCC1 VGLL4 ZFP1 ZNF557 ZNF585B ZNF831 |
High blood pressure (mother) |
3.22 |
17 |
5 |
11.1 |
0.94 |
7.3e-11 |
AGT ARHGAP42 CENPW CLCN6 CNNM2 FES FURIN HOXA10 HOXC8 KANK2 PIGV SENP1 SLC4A7 TMEM170A TNNT3 UBE2Z ZNF831 |
Body mass index (BMI) |
1.37 |
34 |
21 |
46.7 |
-0.20 |
2.4e-01 |
AC006547.14 AC091133.1 ADCY3 ARNTL CARF CNNM2 DHX36 EDEM3 FIBP GALNT4 GRB14 HTR4 MYBPC3 NADK NEK4 OLA1 PEPD POC1B RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC35E2 SLC5A11 SLC9A3R2 SNF8 SNX32 ST5 TCF7L2 TEAD3 THAP3 TRIM73 TRIM8 UBA7 |
Impedance of leg (left) |
2.06 |
64 |
44 |
97.8 |
0.48 |
8.4e-06 |
AC006547.14 AC091133.1 ADCY3 ADM ARC ARVCF ATF1 C2orf69 C4orf3 C8orf58 CASC7 CERS5 CNNM2 CSNK1G3 CTC-228N24.3 CTD-3032J10.3 CYBRD1 DDHD2 DKFZp686O24166 ELP4 FAM108C1 FES FIBP FLJ33630 FURIN GABPB2 GAPVD1 GOLGA1 HAGH HELLS HOXB3 HOXD-AS1 LIMA1 MC1R NADK NEK4 NMT1 NNT NOC3L PAFAH1B1 PASK PLA2G4B PLCD3 PPAP2B PPP6C PRRC2B RNF130 RP11-179B2.2 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 SCRN2 SFXN2 SLC12A2 SLC35E2 SWAP70 TEAD3 TP53INP1 TRIM73 TRIM8 UBA7 ULK4 UQCC1 WNT2B |
Leg predicted mass (left) |
1.84 |
65 |
39 |
86.7 |
-0.43 |
1.1e-04 |
ADAM11 ADCY9 ARVCF C10orf118 C2orf69 CADM2 CDK6 CENPW CNNM2 CPEB4 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC3-AS1 FAM108C1 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 KANSL1 LRRC46 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP13-514E23.2 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 UPF3A UQCC1 ZNF500 |
Trunk fat mass |
1.52 |
45 |
26 |
57.8 |
-0.11 |
4.2e-01 |
ABHD17C ADCY3 ARL17A ARL17B ARNTL CDK6 CNNM2 DHX36 ERAP1 GFPT1 GRB14 HOXA10 HTR4 KANSL1 MRAS MYBPC3 NSF NSFP1 NUDT16L1 OCIAD1 OLA1 PEPD POC1B RERE RP11-179B2.2 RP11-981P6.1 RSRC2 SEPT12 SFXN3 SLC25A37 SLC5A11 SLC9A3R2 SNX11 SNX32 SRD5A3 SRPK1 ST5 THAP3 TRIM47 TRIM73 UBA7 UBN1 UPF3A UQCC1 WNT2B |
Waist circumference |
1.37 |
33 |
18 |
40.0 |
-0.14 |
3.9e-01 |
ACADVL ADCY3 ADCY9 ARNTL CARF CDK6 DHX36 DULLARD FAM108C1 FIBP HOXC8 HTR4 MYBPC3 NADK OLA1 POC1B RP11-179B2.2 RP11-981P6.1 SEPT12 SIPA1 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SNX11 SNX32 SRPK1 ST5 TEAD3 THAP3 TRIM73 UBA7 |
Number of incorrect matches in round |
1.22 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
FURIN PREX1 |
Past tobacco smoking |
1.29 |
7 |
1 |
2.2 |
0.21 |
6.5e-01 |
ADAM1A C17orf68 CADM2 GAPVD1 PDXDC2P PPP6C SH2B3 |
Alcohol usually taken with meals |
1.34 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C1orf84 COMMD7 |
Nervous feelings |
1.39 |
9 |
3 |
6.7 |
-0.06 |
8.8e-01 |
ARL17B CADM2 CNNM2 NEK4 NSF NUP160 PCCB PPP6C SMG6 |
Frequency of tenseness / restlessness in last 2 weeks |
1.18 |
3 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARL17B MMAB NSF |
Hearing difficulty/problems with background noise |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CSK ZNF318 |
Hair/balding pattern: Pattern 2 |
1.38 |
6 |
4 |
8.9 |
-0.82 |
4.3e-02 |
ARL17B C4orf22 COMMD7 CPEB2 FGF5 PRDM8 |
Had menopause |
1.16 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
EXD1 INO80 |
Forced vital capacity (FVC) |
1.76 |
41 |
28 |
62.2 |
-0.28 |
7.3e-02 |
ACP2 ADAM11 ADCY3 ARL17A ARL17B C17orf69 CDK6 CENPW CTC-228N24.3 CYBRD1 DCAF16 FER FHL3 FLJ33630 FMNL3 GABPB2 HTR4 KANSL1 MYBPC3 NOV NSF NSFP1 NUDT16L1 PPP3R1 PREX1 RGS12 RHOC RP11-1055B8.4 RP11-156P1.3 RP11-179B2.2 RP11-379F4.7 RSRC2 SLC12A2 SLC2A4RG SLFNL1 TCP11 TMBIM1 TMEM180 UBE2Z UPF3A ZNF500 |
Heel bone mineral density (BMD) T-score, automated (right) |
1.35 |
12 |
8 |
17.8 |
0.24 |
3.9e-01 |
ACP2 CDK6 CYB5D1 FHL3 KAT5 LRRC55 RERE RP13-514E23.2 SIPA1 UBA7 WNT2B ZNRF3 |
Qualifications: None of the above |
1.30 |
9 |
4 |
8.9 |
0.69 |
4.0e-02 |
ATXN1L IRAK1BP1 KANSL1 MPP6 NUDT16L1 RSRC2 SLC5A11 UBA7 UBE2Z |
Mouth/teeth dental problems |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RASIP1 |
Heart attack |
1.80 |
3 |
2 |
4.4 |
-0.81 |
2.9e-02 |
FES RP1-257A7.5 TCF21 |
Allergy |
1.47 |
19 |
9 |
20.0 |
-0.28 |
2.4e-01 |
C11orf1 C11orf30 C17orf69 CLIC4 EXD1 FES HDAC7 INO80 LIME1 OIP5-AS1 PSMB7 RERE RP11-373D23.3 RP5-1029K10.2 RTF1 SLC15A2 SLC2A4RG SMAD3 TMBIM1 |
Diabetes (self-reported) |
1.51 |
5 |
4 |
8.9 |
0.56 |
3.2e-01 |
DKFZp686O24166 FLJ33630 HHEX TCF7L2 UBA7 |
Hayfever/allergic rhinitis (self-reported) |
1.27 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
C11orf30 SMAD3 |
Medication: Ramipril |
2.31 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARHGAP42 CSK |
Medication: Simvastatin |
2.16 |
6 |
3 |
6.7 |
0.79 |
3.8e-03 |
FES OPRL1 PIGV RASIP1 RGS19 ZNF831 |
Fluid intelligence score |
1.09 |
5 |
3 |
6.7 |
-0.30 |
6.2e-01 |
ATXN1L DCAF16 DKFZp686O24166 FBXO41 UBA7 |
Illnesses of siblings |
1.97 |
3 |
0 |
0.0 |
-0.97 |
2.8e-02 |
FES SH2B3 SLC5A11 |
Neuroticism score |
1.35 |
10 |
4 |
8.9 |
-0.26 |
4.3e-01 |
ADM ARL17B ARNTL ELP4 GOLGA1 NSF NUP160 PCCB PPP6C RERE |
Weight |
1.53 |
59 |
31 |
68.9 |
-0.34 |
3.5e-03 |
ADCY9 ATXN1L C10orf118 C2orf69 CDK6 CNNM2 CSNK1G3 CYBRD1 CYTH1 DCAF16 DHX36 ERAP1 FAM108C1 FIBP GAPVD1 GFER GFPT1 GLYR1 HOXB3 HTR4 KANSL1 LRRC46 NADK NFKBIA NUDT16L1 OCIAD1 OLA1 PEPD PEX1 POC1B POLN ROGDI RP11-179B2.2 RP11-332H18.4 RP11-981P6.1 RSRC2 SENP2 SEPT12 SFXN3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SNX11 SNX32 SRPK1 ST5 TCF7L2 TCP11 TEAD3 TRIM73 TRIM8 UBA7 UBN1 UPF3A UQCC1 WNT2B ZNF500 |
Impedance of arm (right) |
1.67 |
66 |
40 |
88.9 |
0.25 |
2.7e-02 |
AC006547.14 ADM ARL17A ARL17B ARVCF BAHD1 C17orf69 C22orf31 CADM2 CERS5 CTD-3032J10.3 CTSO CYBRD1 DKFZp686O24166 ELP4 FER FIBP GAPVD1 GFPT1 GRB14 HELLS HOXA10 HOXB3 HOXC8 HOXD-AS1 KANSL1 KCNG3 LDB1 LIME1 LSP1 NADK NDUFS4 NEK4 NNT NOC3L NSF NSFP1 OPRL1 PAFAH1B1 PASK PEPD PPP3R1 PPP6C PRRC2B PSMB7 RGS19 RP11-156P1.3 RP11-179B2.2 RP11-373D23.3 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 RYK SCRN2 SENP1 SENP3 SLC35E2 SLC4A7 SLC9A3R2 SNX16 SNX32 TEAD3 TRIM73 TRIM8 UBA7 WNT2B |
Arm fat percentage (right) |
1.56 |
44 |
20 |
44.4 |
0.12 |
4.2e-01 |
ABHD17C AC091133.1 ACADVL ACP2 ADCY3 ADM AP001816.1 ARL17A ARNTL C6orf142 DCAF16 DULLARD EDEM3 EXD1 GFPT1 GRB14 HOXA10 HTR4 KANSL1 MPP6 MYBPC3 NOV NSF NUP160 OIP5-AS1 OLA1 PEPD POC1B POLL RERE RP11-981P6.1 RSRC2 SENP3 SFXN3 SLC25A37 SLC5A11 SNF8 SNX32 ST5 TCF7L2 THAP3 TRIM47 TRIM73 UBA7 |
Trunk fat-free mass |
1.95 |
78 |
56 |
124.4 |
-0.48 |
8.9e-07 |
ADAM11 ADCY3 ADCY9 ADM ARVCF ATXN1L C10orf118 C17orf69 C2orf69 CADM2 CDK6 CENPW CGREF1 CNNM2 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 FAM108C1 FBXW4 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 HOXD-AS1 KCNG3 MED28 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 OIP5-AS1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP11-78O7.2 RP13-514E23.2 RPL39P5 RPS6KL1 RSRC2 S1PR2 SENP2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC35E2 SLC4A7 SLC5A11 SLC9A3R2 SLFNL1 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UQCC1 |
Hip circumference |
1.58 |
46 |
27 |
60.0 |
-0.45 |
9.2e-04 |
ACADVL ADCY3 ANKS3 CDK6 CLCN6 CNNM2 CPEB4 CYBRD1 DHX36 ERAP1 FAM108C1 GAPVD1 GPR137 GRB14 HTR4 MRAS MYBPC3 NADK NFKBIA NPPA OLA1 PDCL2 PEPD RASIP1 RGS19 RP11-179B2.2 RP11-981P6.1 RSRC2 SEPT12 SFXN3 SH2B3 SLC25A37 SLC2A4RG SLC9A3R2 SNX11 SRPK1 ST5 TCF7L2 TEAD3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 UPF3A UQCC1 |
Alcohol intake versus 10 years previously |
1.21 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
EDEM3 RASIP1 UBA7 |
Father's age at death |
1.55 |
2 |
2 |
4.4 |
-1.00 |
2.7e-04 |
FES SH2B3 |
Worrier / anxious feelings |
1.36 |
7 |
3 |
6.7 |
0.05 |
9.2e-01 |
ARNTL CADM2 CNNM2 NEK4 NSF PCCB TEAD3 |
Frequency of tiredness / lethargy in last 2 weeks |
1.20 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
MMAB SNF8 UBE2Z |
Falls in the last year |
1.22 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CASC7 |
Hair/balding pattern: Pattern 3 |
1.36 |
6 |
5 |
11.1 |
0.79 |
6.0e-02 |
ARL17B C17orf69 C4orf22 FGF5 NSF PRDM8 |
Forced expiratory volume in 1-second (FEV1) |
1.74 |
31 |
19 |
42.2 |
-0.18 |
3.2e-01 |
ADCY3 ADO ARHGAP42 ARL17A ARL17B CDK6 CYBRD1 DCAF16 FBXO38 FER FHL3 GOLGA1 HTR4 KANSL1 NFKBIA NSF NSFP1 NUDT16L1 PREX1 RGS12 RHOC RP11-1055B8.4 RP11-156P1.3 RP11-179B2.2 RP11-379F4.7 SLC2A4RG TCP11 TMEM180 UPF3A ZCCHC10 ZNF500 |
Pulse rate |
1.31 |
4 |
3 |
6.7 |
0.34 |
6.6e-01 |
MAPKAP1 NAA16 RBM23 TCF21 |
Qualifications: A levels/AS levels or equivalent |
1.19 |
4 |
2 |
4.4 |
-0.94 |
6.3e-02 |
DCAF16 FBXO41 MPP6 UBA7 |
Mouth/teeth dental problems: Dentures |
1.26 |
4 |
1 |
2.2 |
0.38 |
6.2e-01 |
CBX1 HOXB9 RASIP1 RPS6KB1 |
Asthma |
1.43 |
10 |
3 |
6.7 |
0.61 |
5.9e-02 |
AC074212.6 HHEX HTR4 OIP5-AS1 RERE RP5-1029K10.2 RTF1 SLC2A4RG SMAD3 TCP11 |
Medication: Ibuprofen (e.g. Nurofen) |
1.31 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
RP1-257A7.5 |
Medication: Cholesterol lowering |
2.07 |
6 |
3 |
6.7 |
0.80 |
3.0e-04 |
ARHGAP42 FES OPRL1 RASIP1 RGS19 THAP3 |
Lung cancer (father) |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
RAD52 |
Illnesses of mother |
2.19 |
3 |
1 |
2.2 |
-0.89 |
7.7e-03 |
FES SLC7A1 UBE2Z |
Forced expiratory volume in 1-second (FEV1), Best measure |
1.68 |
29 |
14 |
31.1 |
-0.17 |
3.7e-01 |
ADAM11 ADCY3 ADO ARL17A ARL17B CDK6 CYBRD1 DCAF16 FBXO38 FER FHL3 FMNL3 GABPB2 HTR4 KANSL1 NSF NSFP1 NUDT16L1 PREX1 RGS12 RP11-1055B8.4 RP11-156P1.3 RP11-179B2.2 RP11-379F4.7 TCP11 TMEM180 UPF3A ZCCHC10 ZNF500 |
Pulse wave Arterial Stiffness index |
1.34 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Impedance of arm (left) |
1.63 |
59 |
36 |
80.0 |
0.23 |
5.6e-02 |
AC006547.14 ADM ARL17A ARL17B ARVCF C17orf69 C22orf31 CADM2 CERS5 CTD-3032J10.3 CTSO DKFZp686O24166 ELP4 FAM108C1 FER FIBP GAPVD1 GFPT1 GRB14 HELLS HOXB3 HOXC8 HOXD-AS1 KANSL1 KCNG3 KIF5B LDB1 LIME1 LSP1 MC1R NADK NDUFS4 NEK4 NOC3L NSF NSFP1 OPRL1 PASK PLCD3 PRRC2B PSMB7 RGS19 RP11-156P1.3 RP11-179B2.2 RP11-373D23.3 RP4-605O3.4 RP5-1029K10.2 RYK SCRN2 SENP3 SH2B3 SLC35E2 SLC9A3R2 SNX32 TEAD3 TNNT3 TRIM73 TRIM8 UBA7 |
Arm fat mass (right) |
1.46 |
38 |
21 |
46.7 |
-0.13 |
4.0e-01 |
ABHD17C AC091133.1 ADCY3 ARL17A ARNTL CDK6 CNNM2 DHX36 ERAP1 FIBP GFPT1 GRB14 HTR4 KANSL1 MYBPC3 NADK OLA1 PEPD POC1B RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC25A37 SLC5A11 SLC9A3R2 SNX32 SRPK1 ST5 TCF7L2 TEAD3 THAP3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 UQCC1 |
Trunk predicted mass |
1.95 |
76 |
56 |
124.4 |
-0.48 |
1.1e-06 |
ADAM11 ADCY3 ADCY9 ADM ATXN1L C10orf118 C17orf69 CADM2 CDK6 CENPW CGREF1 CNNM2 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 FAM108C1 FBXW4 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 HOXD-AS1 KCNG3 MED28 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 OIP5-AS1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP11-78O7.2 RP13-514E23.2 RPL39P5 RPS6KL1 RSRC2 S1PR2 SENP2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC35E2 SLC4A7 SLC5A11 SLC9A3R2 SLFNL1 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UQCC1 |
Standing height |
1.72 |
122 |
91 |
202.2 |
-0.31 |
2.1e-04 |
AC074212.6 AC091133.1 ACP2 ADAM11 ADCY3 ADCY9 ADM ADRB1 ANKS3 APOLD1 ARC ARL14EP ARL17A ARL17B ATF1 ATXN1L AZI1 C17orf68 CCT6A CDK6 CENPW CERS5 COPB1 CSNK1G3 CYBRD1 CYTH1 DCAF16 DKFZp686O24166 DNAJC18 EDEM3 EXD1 FER FHL3 GAB1 GAPVD1 GCHFR GFER GFPT1 GLYR1 GOPC GTF2B INO80 ITSN1 KANSL1 KIF5B LIMA1 MAPKAP1 MEA1 MED28 MMACHC MPP6 MYBPC3 MYLPF NEK4 NFKBIA NMT1 NOV NPR3 NSF NSFP1 NUDT16L1 NUP160 OAF OCIAD1 OIP5-AS1 PBX3 PCCB PEX1 PHF21A PIGV PLCD3 POLL PPP3R1 PREX1 PSMD5-AS1 RABGAP1 RASIP1 RGS12 RHOC RP11-1055B8.4 RP11-179B2.2 RP11-332H18.4 RP11-379F4.7 RP13-514E23.2 RP4-605O3.4 RP4-635E18.7 RP5-1029K10.2 RPL39P5 RPS6KL1 RSRC2 RTF1 RYK S1PR2 SEC23IP SENP2 SEPT12 SERPINI1 SH2B3 SIPA1 SLC25A37 SLC5A11 SLC9A3R2 SLFNL1 SMARCA4 SMOC1 SNF8 SNX11 SRPK1 TCP11 TMBIM1 TMEM170A TMEM180 UBE2Z UBN1 UPF3A UQCC1 WNT2B ZNF318 ZNF500 ZNF557 ZNF585B ZNF831 |
Exposure to tobacco smoke at home |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Breastfed as a baby |
1.33 |
4 |
1 |
2.2 |
-0.99 |
1.0e-03 |
ANKRD65 LOC441869 PUSL1 SLC35E2 |
Tense / 'highly strung' |
1.22 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CADM2 RERE |
Seen doctor (GP) for nerves, anxiety, tension or depression |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SGIP1 |
Hair/balding pattern: Pattern 4 |
1.68 |
17 |
11 |
24.4 |
0.44 |
6.6e-02 |
ARL17B C17orf69 C4orf22 CBWD1 CENPW CERS5 CHD6 CLIC4 FGF5 KANSL1 LGR4 LIMA1 NSF PRDM8 RP11-156P1.3 RP4-605O3.4 SMG6 |
Birth weight of first child |
2.24 |
14 |
5 |
11.1 |
-0.92 |
3.6e-08 |
ACADVL ANKRD65 CLCN6 DCAF16 FES FURIN GTF2B HDDC3 NPPA OPRL1 PREX1 RP11-841O20.2 SH2B3 TMEM170A |
Peak expiratory flow (PEF) |
1.57 |
16 |
9 |
20.0 |
-0.32 |
2.0e-01 |
ABCA12 ACADVL ANKRD65 ARL17B DCAF16 FBXO38 HTR4 NSF PUSL1 RASIP1 SLC2A4 SLC9A3R2 TCF21 TCP11 TMEM170A UQCC1 |
Qualifications: O levels/GCSEs or equivalent |
1.38 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
NUDT16L1 RPS6KB1 ZNF500 |
Blood clot in the leg (DVT) |
1.28 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ATP1B1 |
Medication: Paracetamol |
1.36 |
4 |
2 |
4.4 |
0.41 |
5.9e-01 |
ARL17B CGREF1 RP1-257A7.5 UFL1 |
Headache pain in last month |
1.52 |
6 |
4 |
8.9 |
-0.09 |
8.6e-01 |
ARL17B MED19 RP1-257A7.5 SLC24A3 TMEM170A UFL1 |
Medication for cholesterol, blood pressure or diabetes |
3.50 |
17 |
12 |
26.7 |
-0.93 |
3.2e-12 |
ACE ARHGAP42 ATP2B1 CLCN6 CSK FES LFNG OPRL1 PDXK RGS19 RHOC SH2B3 SLC4A7 TCF21 THAP3 UPF3A ZNF831 |
Gout (self-reported) |
1.14 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CGREF1 SH2B3 SIPA1 |
Hypothyroidism/myxoedema (self-reported) |
1.41 |
7 |
4 |
8.9 |
0.72 |
6.9e-02 |
ADAM1A BRAP NAA25 PUSL1 RP11-6N17.6 SH2B3 SRPK1 |
Medication: Amlodipine |
3.36 |
14 |
10 |
22.2 |
0.90 |
5.5e-08 |
ARHGAP42 CLCN6 FAM108C1 FES GLYR1 KDM2B LSP1 RHOC RP4-635E18.7 SENP3 SLC4A7 TNNT3 WNT2B ZNF318 |
Medication: Ventolin 100micrograms inhaler |
1.15 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SMAD3 |
Birth weight |
2.34 |
24 |
16 |
35.6 |
-0.29 |
1.4e-01 |
ACADVL ACAP1 ADAM1A ADCY9 ADRB1 BRAP C10orf26 C11orf1 CDK6 CNNM2 DCAF16 DULLARD ELP5 FES FURIN HHEX HTRA1 PREX1 PSMD5-AS1 RABGAP1 S1PR2 SH2B3 SLC2A4 ZNRF3 |
High blood pressure (siblings) |
2.60 |
10 |
2 |
4.4 |
0.98 |
2.5e-09 |
ACP2 ADO ARHGAP42 CLCN6 FES JPH2 MTHFR SGIP1 SH2B3 SLC4A7 |
Forced vital capacity (FVC), Best measure |
1.68 |
40 |
28 |
62.2 |
-0.31 |
4.3e-02 |
ACP2 ADAM11 ADCY3 ANKS3 ARL17A ARL17B CDK6 CENPW CYBRD1 DCAF16 FER FHL3 FLJ33630 FMNL3 GABPB2 HTR4 KANSL1 MYBPC3 NOV NSF NSFP1 NUDT16L1 PPP3R1 PREX1 RGS12 RHOC RP11-1055B8.4 RP11-156P1.3 RP11-179B2.2 RP11-379F4.7 RSRC2 SLC12A2 SLC2A4RG SLFNL1 TCP11 TMBIM1 TMEM180 UBE2Z UPF3A ZNF500 |
Body fat percentage |
1.63 |
47 |
24 |
53.3 |
0.02 |
8.9e-01 |
ABHD17C AC091133.1 ADCY3 ADM ARL17A ARL17B ARNTL CHD6 CTC-228N24.3 DHX36 EDEM3 ERAP1 FLJ33630 GFPT1 GRB14 HELLS HOXA10 HOXC8 HTR4 KANSL1 MC1R MPP6 MYBPC3 NOV NSF OIP5-AS1 PDCL2 PEPD POC1B POLL RERE RP11-981P6.1 RSRC2 SENP3 SFXN3 SLC25A37 SLC5A11 SLC9A3R2 SNX32 SRD5A3 SRPK1 TCF7L2 THAP3 TRIM47 TRIM73 UBA7 WNT2B |
Leg fat percentage (right) |
1.68 |
40 |
20 |
44.4 |
0.30 |
5.8e-02 |
ABHD17C ADCY3 ADM ARNTL CARF CRK CTC-228N24.3 DCAF16 EDEM3 ERAP1 EXD1 FIBP FLJ33630 GRB14 GTF2B HELLS HTR4 MPP6 MYBPC3 NMT1 NOV OIP5-AS1 OLA1 PEPD RERE RP11-981P6.1 RSRC2 SFXN3 SLC12A2 SLC2A4RG SLC5A11 SLC9A3R2 SNX32 ST5 TCF7L2 THAP3 TRIM73 UBA7 UQCC1 WNT2B |
Arm fat-free mass (right) |
1.81 |
70 |
41 |
91.1 |
-0.43 |
6.7e-05 |
AC006547.14 ADAM11 ADCY9 ADM ARVCF ATXN1L C10orf118 CADM2 CDK6 CENPW CGREF1 CNNM2 CSNK1G3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 FAM108C1 FBXW4 FHL3 FIBP GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 KCNG3 LIME1 MED28 NADK NFKBIA NMT1 NOV PEX1 PLCD3 PPP3R1 PPP6C PRRC2B PSMB7 RASIP1 RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RSRC2 S1PR2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SNX32 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UQCC1 |
Comparative body size at age 10 |
1.49 |
16 |
10 |
22.2 |
-0.68 |
2.0e-03 |
ADCY3 ADCY9 CADM2 CERS5 LIMA1 MYBPC3 NADK NME6 RP4-605O3.4 SIPA1 SLC35E2 SMG6 TEAD3 THAP3 VGLL4 WNT2B |
Worry too long after embarrassment |
1.43 |
5 |
3 |
6.7 |
-0.97 |
1.5e-05 |
ARNTL GAPVD1 PCCB PPP6C RGS12 |
Wheeze or whistling in the chest in last year |
1.18 |
4 |
4 |
8.9 |
-0.06 |
9.4e-01 |
C11orf1 SLC2A4RG SMAD3 UBA7 |
Number of children fathered |
1.10 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CADM2 |
Age at first live birth |
1.19 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
DCAF16 UBA7 |
Pulse wave peak to peak time |
1.34 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ADAM1A |
Shortness of breath walking on level ground |
1.16 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
SGIP1 |
Qualifications: College or University degree |
1.18 |
15 |
6 |
13.3 |
-0.68 |
5.7e-03 |
ARL17B DCAF16 FBXO41 GTF2B KANSL1 KIF5B MMACHC MPP6 PPP2R2D RGS12 RP11-1055B8.4 RP11-166B2.1 SIRT1 SLC5A11 UBA7 |
Medication for pain relief, constipation, heartburn |
1.34 |
5 |
3 |
6.7 |
-0.99 |
9.3e-04 |
C17orf68 CGREF1 FAM108C1 RP1-257A7.5 UFL1 |
Neck or shoulder pain in last month |
1.14 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ATXN1L |
Medication: Blood pressure |
4.34 |
42 |
23 |
51.1 |
0.97 |
2.4e-30 |
AC091133.1 ACADVL ACE ACP2 ADAM1A ADRB1 ARHGAP42 ATP2B1 BICC1 C4orf22 CLCN6 CSK CYB5D1 FAM108C1 FBXO41 FES FGF5 FURIN HOXA10 KDM2B LFNG LSP1 NME6 NOC3L NUP160 PDXK PLCB1 RGS19 RHOC RP11-819C21.1 RP4-635E18.7 SENP1 SH2B3 SLC2A4 SLC4A7 TCF21 THAP3 TNNI2 TNNT3 UPF3A WNT2B ZNF831 |
Angina (self-reported) |
1.95 |
6 |
2 |
4.4 |
0.77 |
5.3e-03 |
FES FURIN OPRL1 RGS19 RP1-257A7.5 TCF21 |
Migraine (self-reported) |
1.47 |
4 |
1 |
2.2 |
0.31 |
6.1e-01 |
RP1-257A7.5 SFXN2 SLC24A3 UFL1 |
Medication: Ibuprofen |
1.28 |
2 |
0 |
0.0 |
0.00 |
1.0e+00 |
RP1-257A7.5 UBE2E3 |
Medication: Allopurinol |
1.14 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
CGREF1 |
Mean time to correctly identify matches |
1.53 |
9 |
8 |
17.8 |
-0.16 |
6.5e-01 |
ARL17A BRAP KANSL1 NAA25 NSF NSFP1 OLA1 PHF21A SH2B3 |
Whole body fat mass |
1.48 |
43 |
24 |
53.3 |
-0.10 |
4.9e-01 |
ABHD17C ADCY3 ARL17A ARL17B ARNTL CDK6 CNNM2 DHX36 ERAP1 FIBP GFPT1 GRB14 HTR4 KANSL1 MRAS MYBPC3 OCIAD1 OLA1 PEPD POC1B RERE RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC25A37 SLC2A4RG SLC5A11 SLC9A3R2 SNX11 SNX32 SRPK1 ST5 TCF7L2 THAP3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 UPF3A UQCC1 WNT2B |
Leg fat mass (right) |
1.47 |
35 |
22 |
48.9 |
-0.14 |
3.8e-01 |
ADCY3 ARNTL CARF CDK6 DHX36 ERAP1 FIBP GRB14 HTR4 MPP6 MYBPC3 NADK OLA1 PEPD POC1B RERE RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC25A37 SLC2A4RG SLC5A11 SLC9A3R2 SNX32 SRPK1 ST5 TCF7L2 TEAD3 THAP3 TRIM73 TRIM8 UBA7 UBN1 WNT2B |
Arm predicted mass (right) |
1.83 |
67 |
41 |
91.1 |
-0.42 |
1.1e-04 |
AC006547.14 ADAM11 ADCY9 ADM ARVCF ATXN1L C10orf118 CADM2 CDK6 CENPW CNNM2 CSNK1G3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 FAM108C1 FBXW4 FHL3 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 LIME1 MED28 NADK NFKBIA NMT1 NOV OIP5-AS1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B PSMB7 RASIP1 RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RSRC2 S1PR2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SNX32 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UQCC1 |
Pulse rate, automated reading |
1.39 |
20 |
10 |
22.2 |
0.28 |
2.1e-01 |
ACP2 ANKS3 C11orf1 C6orf142 CES2 CSNK1G3 DNAJC18 HIBCH LDB1 MAPKAP1 NAA16 NUDT16L1 PBX3 PHACTR4 RBM23 SEC31B SENP2 TCF21 TMEM26 UBA7 |
Alcohol intake frequency. |
1.06 |
9 |
3 |
6.7 |
0.19 |
6.2e-01 |
ARL17B CADM2 CGREF1 MYBPC3 RASIP1 RGS12 RP1-257A7.5 RPS6KB1 UBA7 |
Comparative height size at age 10 |
1.65 |
68 |
42 |
93.3 |
-0.32 |
5.3e-03 |
AC010883.5 ADAM11 ADCY3 ADCY9 ARL17A ATXN1L C1orf84 CDK6 CENPW CYBRD1 CYTH1 DCAF16 DKFZp686O24166 DNAJC18 FAM108C1 FBXW4 FER GFER GFPT1 GLYR1 GTF2B HADH HOXB3 IGFBP3 KANSL1 KIF5B LSM11 MED28 MMACHC MYBPC3 NEK4 NFKBIA NOV NPR3 NSF NUDT16L1 OCIAD1 PCCB PIGV PLCD3 PREX1 RASIP1 RGS12 RP11-179B2.2 RP11-332H18.4 RP4-635E18.7 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SH2B3 SLC25A37 SLC9A3R2 SLFNL1 SMOC1 SRPK1 TCP11 TMBIM1 TMEM170A UBE2Z UPF3A UQCC1 WNT2B ZFP1 ZNF500 ZNF557 ZNF585B |
Suffer from 'nerves' |
1.28 |
5 |
3 |
6.7 |
0.96 |
1.0e-02 |
CADM2 MYBPC3 NUP160 RNF130 SMG6 |
Overall health rating |
1.43 |
6 |
4 |
8.9 |
0.29 |
5.7e-01 |
ATXN1L HTR4 PBX3 SLC5A11 SNX32 UBA7 |
Age at last live birth |
1.26 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
AFAP1 MAPK4 UBA7 |
Leg pain on walking |
1.07 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Medication: Aspirin |
2.06 |
2 |
1 |
2.2 |
-0.18 |
7.8e-01 |
FES OPRL1 |
Knee pain experienced in last month |
1.20 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
RP11-981P6.1 UQCC1 |
Hypertension (Self-reported) |
6.07 |
143 |
92 |
204.4 |
0.98 |
4.1e-115 |
ABCA12 AC006111.1 AC091133.1 ACADVL ACE ACP2 ACTRT3 ADAM1A ADO ADRB1 ADRB2 AGT ANKS3 ARHGAP42 ARL17B ARNTL ATP2B1 BICC1 BRAP C10orf118 C11orf1 C22orf31 C4orf22 CACNB2 CENPW CERS5 CLCN6 CNNM2 CSK CTD-3032J10.3 CTSZ CYB5D1 DCAF16 DKFZp686O24166 ENPEP ERAP1 EXD1 FAM108C1 FCN3 FES FGF5 FURIN GAB1 GCHFR GLTP GLYR1 GOPC GOSR2 GTF2B GUCY1A3 HDAC7 HELLS HOXA10 HOXB9 HOXC8 HRCT1 HTR4 INO80 IRAK1BP1 ITGB5 KDM2B LA16c-358B7.3 LFNG LIMA1 LIME1 LSP1 MAPKAP1 MARK2 MED21 MRAS MTHFR NAA25 NAT15 NELFCD NME6 NMT1 NOC3L NPPA NPR3 NSUN6 NUDT16L1 NUP160 OIP5-AS1 OPRL1 PDXK PIGV PLCB1 PLEKHM2 PRDM8 PRKD3 PTPN12 RASIP1 RGS19 RHOC RP11-1055B8.4 RP11-332H18.4 RP11-379F4.7 RP11-588K22.2 RP11-819C21.1 RP11-981P6.1 RP13-514E23.2 RP4-605O3.4 RP4-635E18.7 RTF1 RYK SENP1 SENP3 SFXN2 SGOL1 SH2B3 SIPA1 SLC12A2 SLC25A37 SLC2A4 SLC4A7 SLC5A11 SNF8 SNX16 SNX31 SOX6 SPEN SWAP70 TBC1D19 TH1L THAP3 TMEM26 TNNI2 TNNT3 TP53INP1 TRIM47 TRIM59 TUBB1 UBAP1 UBE2Z UFL1 UPF3A VGLL4 WNT2B ZBTB46 ZNF318 ZNF443 ZNF831 ZNRF3 |
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) |
1.17 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
MARK2 |
Illnesses of father: Heart disease |
2.07 |
6 |
3 |
6.7 |
0.77 |
8.6e-03 |
CDH13 FES RGS19 RP1-257A7.5 SMAD3 TCF21 |
Illnesses of siblings: Diabetes |
1.18 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCF7L2 |
Smoking status: Previous |
1.16 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
CADM2 SH2B3 |
Forced expiratory volume in 1-second (FEV1), predicted |
1.43 |
7 |
5 |
11.1 |
-0.36 |
3.8e-01 |
ADCY3 CDK6 DCAF16 NUDT16L1 SRPK1 TCP11 UQCC1 |
Whole body fat-free mass |
1.91 |
75 |
55 |
122.2 |
-0.53 |
1.0e-07 |
ADAM11 ADCY9 ADM ARVCF ATXN1L C10orf118 C17orf69 C2orf69 CADM2 CDK6 CENPW CGREF1 CNNM2 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 EFCAB13 FAM108C1 FBXW4 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 MED28 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 OIP5-AS1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SH2B3 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UPF3A UQCC1 ZNF500 |
Leg fat-free mass (right) |
1.87 |
66 |
43 |
95.6 |
-0.44 |
4.4e-05 |
AC006547.14 ADAM11 ADCY9 ADM ARVCF C10orf118 C2orf69 CADM2 CDK6 CENPW CNNM2 CPEB4 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 EFCAB13 FAM108C1 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 KANSL1 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 PEX1 PLA2G4B PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-981P6.1 RP13-514E23.2 RSRC2 SENP2 SEPT12 SFXN2 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TRIM8 UBA7 UBN1 UPF3A UQCC1 ZNF500 |
Arm fat percentage (left) |
1.55 |
43 |
22 |
48.9 |
0.02 |
9.2e-01 |
ABHD17C AC091133.1 ACADVL ACP2 ADCY3 ADM AP001816.1 ARL17A ARNTL C6orf142 CHD6 DCAF16 DHX36 EDEM3 EXD1 FIBP GALNT4 GFPT1 GRB14 HOXA10 HOXC8 HTR4 KANSL1 MPP6 MYBPC3 NUP160 OIP5-AS1 PEPD POC1B POLL RERE RP11-981P6.1 RSRC2 SENP3 SFXN3 SLC5A11 SNF8 SNX32 TCF7L2 THAP3 TRIM47 TRIM73 UBA7 |
Handedness (chirality/laterality): Left-handed |
1.31 |
3 |
2 |
4.4 |
0.00 |
1.0e+00 |
ARL17A NSF NSFP1 |
Mood swings |
1.14 |
6 |
2 |
4.4 |
0.37 |
4.8e-01 |
ACP2 ARL17B NSF NUP160 SLC5A11 UBA7 |
Loneliness, isolation |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MYBPC3 NUP160 |
Ever had bowel cancer screening |
1.03 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Diabetes diagnosed by doctor |
1.62 |
6 |
5 |
11.1 |
0.56 |
2.4e-01 |
DKFZp686O24166 HHEX PLA2G4B TCF7L2 UBA7 ZBTB46 |
Qualifications: nursing, teaching |
1.00 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
UBA7 |
Eye problems/disorders: Cataract |
0.89 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
SLC24A3 |
Mouth/teeth dental problems: Mouth ulcers |
1.06 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ITGB3 TRIM59 |
Medication for cholesterol |
3.13 |
18 |
8 |
17.8 |
-0.94 |
1.1e-09 |
AGT ARHGAP42 C4orf22 CGREF1 FES HOXA10 MC1R NUDT16L1 PIGV RASIP1 RHOC SENP1 SH2B3 TNNT3 WNT2B ZBTB46 ZNF500 ZNF831 |
Breast cancer (self-reported) |
1.16 |
2 |
2 |
4.4 |
0.00 |
1.0e+00 |
SLC4A7 TOX3 |
Asthma (self-reported) |
1.42 |
10 |
3 |
6.7 |
0.61 |
6.1e-02 |
AC074212.6 HHEX HTR4 OIP5-AS1 RERE RP5-1029K10.2 RTF1 SLC2A4RG SMAD3 TCP11 |
Medication: Aspirin |
2.04 |
2 |
1 |
2.2 |
0.10 |
8.6e-01 |
FES OPRL1 |
Medication: Gliclazide |
1.28 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
TCF7L2 |
Illnesses of father: None of the above (group 1) |
2.30 |
1 |
1 |
2.2 |
0.17 |
7.9e-01 |
FES |
Smoking status: Current |
1.42 |
4 |
1 |
2.2 |
-1.00 |
2.8e-03 |
GOLGA1 MAPKAP1 PBX3 PPP6C |
Forced expiratory volume in 1-second (FEV1), predicted percentage |
1.32 |
7 |
4 |
8.9 |
-0.29 |
5.2e-01 |
ARL17B FBXO38 HTR4 NSF TCP11 TMEM170A UQCC1 |
Whole body water mass |
1.92 |
73 |
59 |
131.1 |
-0.52 |
1.3e-07 |
ADAM11 ADCY9 ADM ARVCF ATXN1L C10orf118 C2orf69 CADM2 CDK6 CENPW CGREF1 CNNM2 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 FAM108C1 FBXW4 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 MED28 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 OIP5-AS1 PEX1 PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SH2B3 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TMBIM1 TNS1 TRIM8 UBA7 UBE2Z UBN1 UPF3A UQCC1 ZNF500 |
Leg predicted mass (right) |
1.88 |
67 |
44 |
97.8 |
-0.46 |
1.7e-05 |
AC006547.14 ADAM11 ADCY9 ADM ARVCF C10orf118 C2orf69 CADM2 CDK6 CENPW CNNM2 CPEB4 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 EFCAB13 FAM108C1 FES FHL3 FLJ33630 FURIN GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 LRRC46 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 PEX1 PLA2G4B PLCD3 PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP13-514E23.2 RSRC2 SENP2 SEPT12 SFXN2 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SMOC1 SNX11 SRPK1 TCP11 TEAD3 TRIM8 UBA7 UBN1 UPF3A UQCC1 ZNF500 |
Arm fat mass (left) |
1.44 |
38 |
20 |
44.4 |
-0.15 |
3.3e-01 |
ABHD17C AC091133.1 ADCY3 ARL17A ARNTL CDK6 CNNM2 DHX36 ERAP1 FIBP GALNT4 GFPT1 GRB14 HTR4 KANSL1 MYBPC3 NADK OLA1 PEPD POC1B RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC25A37 SLC5A11 SLC9A3R2 SNX32 SRPK1 ST5 TCF7L2 TEAD3 THAP3 TRIM47 TRIM73 TRIM8 UBA7 UBN1 |
Number of self-reported non-cancer illnesses |
2.25 |
10 |
3 |
6.7 |
0.91 |
2.4e-04 |
CLCN6 FBXO41 NUDT16L1 RGS19 RP5-1029K10.2 SH2B3 SLC2A4RG ZNF318 ZNF831 ZNRF3 |
Miserableness |
1.11 |
5 |
1 |
2.2 |
0.42 |
4.8e-01 |
ACP2 ARL17B MMAB NUP160 UBA7 |
Guilty feelings |
1.23 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
ARNTL |
Medication: Blood pressure |
4.83 |
58 |
35 |
77.8 |
0.97 |
4.6e-44 |
ABCA12 ACE ACP2 ACTRT3 ADRB1 AGT ARHGAP42 ARL17B C11orf1 C4orf22 CACNB2 CENPW CLCN6 CNNM2 CSK CTD-3032J10.3 CYB5D1 EXD1 FAM108C1 FES FGF5 FURIN GTF2B GUCY1A3 HOXA10 HOXC8 JPH2 KAT5 KDM2B LFNG LIME1 LSP1 MC1R MRAS NME6 NUDT16L1 OPRL1 PDXK PIGV PLCB1 PRKD3 RHOC RP11-1055B8.4 RP11-588K22.2 RP11-819C21.1 SH2B3 SIPA1 SLC2A4RG SLC4A7 SLC7A1 TNNI2 TNNT3 WNT2B ZBTB46 ZNF318 ZNF500 ZNF831 ZNRF3 |
High cholesterol (Self-reported) |
2.01 |
12 |
9 |
20.0 |
0.88 |
1.9e-06 |
ARHGAP42 CGREF1 DCAF16 OPRL1 PIGV RASIP1 RGS12 RGS19 SIDT2 SMARCA4 TMBIM1 TRIM47 |
Medication: Bendroflumethiazide |
3.45 |
20 |
12 |
26.7 |
0.95 |
7.9e-14 |
ACP2 ARHGAP42 ATP2B1 CACNB2 CSK FES GFPT1 HOXA10 LSP1 PIGV PLCB1 RHOC SLC4A7 SLC7A1 TCF21 TNNI2 TNNT3 UBAP1 WNT2B ZNF831 |
Medication: Paracetamol |
1.29 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ARL17B |
Medication: Lisinopril |
2.46 |
4 |
0 |
0.0 |
0.95 |
5.1e-02 |
ARHGAP42 LSP1 NME6 ZNF831 |
Illnesses of father: High blood pressure |
2.73 |
3 |
1 |
2.2 |
0.99 |
1.1e-05 |
C4orf22 FES UPF3A |
Ever smoked |
1.33 |
3 |
1 |
2.2 |
0.00 |
1.0e+00 |
CADM2 GAPVD1 PDXDC2P |
Basal metabolic rate |
1.81 |
71 |
54 |
120.0 |
-0.49 |
2.0e-06 |
AC006547.14 ADAM11 ADCY9 ADM ARVCF ATXN1L C10orf118 C2orf69 CADM2 CDK6 CENPW CNNM2 CSNK1G3 CTC-228N24.3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 DNAJC3-AS1 FAM108C1 FHL3 FLJ33630 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 MED28 NADK NFKBIA NMT1 NOV NPR3 NUDT16L1 PEX1 PLCD3 POLN PPP3R1 PPP6C PRRC2B RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RSRC2 S1PR2 SENP2 SEPT12 SFXN2 SH2B3 SLC12A2 SLC25A37 SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SNX11 SRPK1 ST5 TCP11 TEAD3 TNS1 TRIM8 UBA7 UBE2Z UBN1 UPF3A UQCC1 ZNF500 |
Leg fat percentage (left) |
1.67 |
40 |
20 |
44.4 |
0.23 |
1.3e-01 |
ABHD17C ADCY3 ADM ARNTL CARF CRK CTC-228N24.3 DCAF16 EDEM3 EXD1 FIBP FLJ33630 GRB14 GTF2B HELLS HTR4 MAPKAP1 MPP6 MYBPC3 NMT1 NOV OIP5-AS1 PEPD POC1B RERE RP11-981P6.1 RSRC2 SFXN3 SLC12A2 SLC2A4RG SLC5A11 SLC9A3R2 SNX32 ST5 TCF7L2 THAP3 TRIM73 UBA7 UQCC1 WNT2B |
Arm fat-free mass (left) |
1.81 |
64 |
44 |
97.8 |
-0.44 |
7.1e-05 |
ADAM11 ADCY9 ADM ATXN1L C10orf118 CADM2 CDK6 CENPW CNNM2 CSNK1G3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 FAM108C1 FBXW4 FHL3 GAPVD1 GFER GLYR1 GOLGA1 HOXB3 LIME1 MED28 NADK NFKBIA NMT1 NOV PEX1 PLCD3 PPP3R1 PPP6C PRRC2B PSMB7 RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RSRC2 S1PR2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SNX11 SNX32 SRPK1 ST5 TCP11 TEAD3 TNS1 TRIM8 UBA7 UBE2Z UBN1 UPF3A UQCC1 |
Average weekly beer plus cider intake |
1.07 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
MYBPC3 UBA7 |
Risk taking |
1.21 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
CADM2 |
Diastolic blood pressure, automated reading |
4.80 |
132 |
86 |
191.1 |
0.91 |
1.2e-60 |
AC006111.1 AC008865.1 AC010883.5 AC091133.1 AC099850.1 ACADVL ACP2 ADAM1A ADM ADO ADRB1 AGT AGTRAP ARHGAP42 ARNTL ATP2B1 BRAP C10orf118 C1orf84 C4orf22 C4orf3 CACNB2 CDH13 CENPW CERS5 CLCN6 CLIC4 CNNM2 CPEB4 CSK CSNK1G3 CTSZ CYB5D1 CYTH1 DCAF16 DULLARD EDEM3 EIF2AK4 ENPEP ERAP1 EXD1 FAM108C1 FBXO41 FES FGF5 FIBP FURIN GCHFR GLS GLTP GUCY1A3 HDAC7 HELLS HIBCH HOXA10 IGFBP3 INO80 IPO11 IRAK1BP1 ITGB5 ITSN1 KAT5 LFNG LIMA1 LIME1 LRIG2 LSP1 MAPKAP1 MAPKBP1 MECR MED19 MTHFR NAA25 NME6 NMT1 NOC3L NOV NSUN6 NUDT16L1 NUP160 OIP5-AS1 PLA2G4B PLEKHH2 POLI RABL2A RERE RGS19 RHOC RNF141 RNPS1 RP11-332H18.4 RP11-379F4.7 RP11-819C21.1 RP13-514E23.2 RP4-605O3.4 RP5-1029K10.2 RPL39P5 SEC31B SENP2 SH2B3 SIPA1 SIRT4 SLC15A2 SLC16A1 SLC24A3 SLC25A37 SLC2A4RG SLC5A11 SLC9A3R2 SLFNL1 SMG6 SMOC1 SNX32 SWAP70 TBC1D19 TEX2 TH1L TMEM26 TMEM87B TNNI2 TNNT3 TRAFD1 TRIM73 TRPV4 TSNARE1 TUBB1 UBA7 UBE2Z ULK4 WNT2B ZNF598 ZNF831 |
Myopia |
1.21 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
WNT2B |
Vascular/heart problems diagnosed by doctor |
5.91 |
130 |
82 |
182.2 |
-0.98 |
1.3e-102 |
ABCA12 AC006111.1 AC006547.14 AC091133.1 ACADVL ACE ACP2 ACTRT3 ADAM1A ADO ADRB1 ADRB2 AGT ANKS3 ARHGAP42 ARL17B ARNTL ATP2B1 BRAP C10orf118 C11orf1 C1orf84 C4orf22 CACNB2 CASC7 CENPW CERS5 CLCN6 CNNM2 CSK CTD-3032J10.3 CYB5D1 DCAF16 ENPEP ERAP1 EXD1 FAM108C1 FBXO41 FCN3 FES FGF5 FURIN GAB1 GCHFR GLTP GOPC GOSR2 GTF2B HDAC7 HOXA10 HOXB9 HOXC8 HRCT1 IBA57 INO80 IRAK1BP1 ITGB5 JPH2 KDM2B LA16c-358B7.3 LFNG LIME1 LSP1 MARK2 MED21 MRAS MTHFR NAA25 NAT15 NME6 NOC3L NPR3 NSUN6 NUDT16L1 NUP160 OIP5-AS1 OLA1 OPRL1 PDXK PIGV PLCB1 PRDM8 PRKD3 PTPN12 RASIP1 RGS19 RHOC RP11-379F4.7 RP11-588K22.2 RP11-819C21.1 RP4-605O3.4 RP4-635E18.7 RP5-1029K10.2 RSRC2 RTF1 RYK SENP1 SENP3 SFXN2 SH2B3 SIPA1 SLC17A6 SLC2A4 SLC4A7 SLC5A11 SNF8 SNX16 SOX6 SWAP70 TBC1D19 TCF21 TH1L THAP3 TMEM26 TNNI2 TNNT3 TP53INP1 TRAFD1 TRIM47 UBAP1 UBE2E3 UBE2Z UGT2B7 VGLL4 WNT2B ZBTB46 ZNF318 ZNF443 ZNF831 ZNRF3 |
Cholesterol lowering medication |
1.87 |
7 |
3 |
6.7 |
0.97 |
9.0e-08 |
DCAF16 OPRL1 PIGV RGS19 SIDT2 SMARCA4 TCF7L2 |
Pain experienced in last month |
1.23 |
2 |
1 |
2.2 |
0.00 |
1.0e+00 |
ATXN1L UFL1 |
Heart attack/myocardial infarction (self-reported) |
1.78 |
4 |
2 |
4.4 |
0.53 |
2.2e-01 |
FES RP1-257A7.5 SH2B3 TCF21 |
Deep venous thrombosis (DVT) (self-reported) |
1.25 |
1 |
1 |
2.2 |
0.00 |
1.0e+00 |
ATP1B1 |
Heart disease (siblings) |
1.37 |
1 |
0 |
0.0 |
0.00 |
1.0e+00 |
FES |
Impedance of whole body |
1.80 |
73 |
55 |
122.2 |
0.42 |
4.0e-05 |
AC006547.14 ADCY3 ADM ARL17A ARL17B ARVCF ATF1 C17orf69 C2orf69 C4orf3 CADM2 CASC7 CERS5 CNNM2 CSNK1G3 CTC-228N24.3 CTD-3032J10.3 CTSO CYBRD1 CYP2C8 DDHD2 DKFZp686O24166 ELP4 FAM108C1 FER FIBP FLJ33630 GAPVD1 GOLGA1 GRB14 HELLS HOXB3 HOXC8 HOXD-AS1 LIMA1 LIME1 MC1R NADK NDUFS4 NEK4 NMT1 NNT NOC3L NSF NSFP1 OPRL1 PAFAH1B1 PASK PLA2G4B PLCD3 PPP6C PRKD3 PRRC2B RGS19 RP11-156P1.3 RP11-179B2.2 RP4-605O3.4 RP5-1029K10.2 RPS6KB1 RYK SCRN2 SENP1 SENP3 SLC12A2 SLC35E2 SNX32 SWAP70 TEAD3 TRIM73 TRIM8 UBA7 UQCC1 WNT2B |
Leg fat mass (left) |
1.46 |
35 |
22 |
48.9 |
-0.19 |
2.3e-01 |
ABHD17C ADCY3 ARNTL CARF CDK6 DHX36 ERAP1 FIBP GRB14 HTR4 MYBPC3 NADK OLA1 PEPD POC1B RERE RP11-179B2.2 RP11-981P6.1 RSRC2 SFXN3 SLC25A37 SLC2A4RG SLC5A11 SLC9A3R2 SNX32 SRPK1 ST5 TCF7L2 TEAD3 THAP3 TRIM73 TRIM8 UBA7 UBN1 WNT2B |
Arm predicted mass (left) |
1.81 |
65 |
43 |
95.6 |
-0.45 |
4.3e-05 |
ADAM11 ADCY9 ADM ATXN1L C10orf118 CADM2 CDK6 CENPW CNNM2 CSNK1G3 CYBRD1 CYTH1 DCAF16 DHX36 DNAJC18 FAM108C1 FBXW4 FHL3 GAPVD1 GFER GLYR1 GOLGA1 HELLS HOXB3 MED28 NADK NFKBIA NMT1 NOV PEX1 PLCD3 PPP3R1 PPP6C PRRC2B PSMB7 RP11-179B2.2 RP11-332H18.4 RP11-373D23.3 RP13-514E23.2 RPL39P5 RSRC2 S1PR2 SENP3 SEPT12 SFXN2 SH2B3 SLC25A37 SLC2A4RG SLC35E2 SLC5A11 SLC9A3R2 SLFNL1 SNX11 SNX32 SRPK1 ST5 TCP11 TEAD3 TMBIM1 TRIM8 UBA7 UBE2Z UBN1 UPF3A UQCC1 |